Stereotactic radiotherapy reduces anti-VEGF injection requirements in neovascular age-related macular degeneration
1. Fewer anti-VEGF intravitreal injections were required in the SRT group over 2 years. 2. Change in visual acuity was ...
Tag: vision loss
#VisualAbstract: Low-Dose Daily Aspirin does not Affect the Progression of Age-Related Macular Degeneration
Click here to read this study in JAMA Ophthalmology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Nanoscope Therapeutics: Gene Therapy Improves Visual Acuity in Patients with Retinitis Pigmentosa
Gene therapy demonstrated clinically meaningful vision improvement in legally blind individuals. The therapy is capable of restoring vision even in ...
High dose aflibercept may be promising for treatment of age-related macular degeneration
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
Avacincaptad pegol reduces the rate of age-related macular degeneration in geographic atrophy
1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative macular neovascularization was comparable among treatment groups. Evidence ...
Heavy smoking is associated with visual field loss in glaucoma
1. In a cohort of about 500 eyes with primary open-angle glaucoma (POAG), higher smoking intensity in pack-years was significantly ...
Monthly brolucizumab is noninferior to aflibercept in treating recalcitrant wet age-related macular degeneration
1. In a phase 3a randomized trial comparing intravitreal brolucizumab to aflibercept for refractory neovascular age-related macular degeneration (nAMD), there ...